Inspire Medical Systems Inc INSP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
Inspire Medical Systems, Inc. to Present at the Stifel 2026 Healthcare Conference
Inspire Medical Systems, Inc. Announces Third Quarter 2026 Financial Results
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Trading Information
- Previous Close Price
- $59.12
- Day Range
- $57.80–59.49
- 52-Week Range
- $38.91–147.03
- Bid/Ask
- $55.60 / $61.00
- Shares Outstanding
- 28.97M
- Market Cap
- $1.72B
- Volume/Avg
- 580,811 / 759,949
Key Statistics
- Price/Earnings (Normalized)
- 29.27
- Price/Sales
- 1.95
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.91%
Company Profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,333
- Website
- https://www.inspiresleep.com
Valuation
Metric | INSP |
|---|---|
Price/Earnings (Normalized) | 29.27 |
Price/Book Value | 2.08 |
Price/Sales | 1.95 |
Price/Cash Flow | 9.37 |
Price/Earnings
INSP
Financial Strength
Metric | INSP |
|---|---|
Quick Ratio | 4.45 |
Current Ratio | 6.45 |
Interest Coverage | — |
Quick Ratio
INSP
Profitability
Metric | INSP |
|---|---|
Return on Assets (Normalized) | 6.55% |
Return on Equity (Normalized) | 7.58% |
Return on Invested Capital (Normalized) | 5.89% |
Return on Assets
INSP
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|#%sHnrC | LOCK|rzY< | $181B | |||
| Medtronic PLC MDT | LOCK|%<^##P@ | LOCK|V?VC< | $131B | |||
| Stryker Corp SYK | LOCK|!Mc<n!? | LOCK|K%< | $121B | |||
| Boston Scientific Corp BSX | LOCK|B#Y%dm | LOCK|JBTPR | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|!bZ#<!@D | LOCK|?^kD | $61B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|@vYZ@V | LOCK|?G | $37B | |||
| DexCom Inc DXCM | LOCK|>pfYp>Gc | LOCK|!>t% | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|@! | LOCK|sH@ | $30B | |||
| Steris PLC STE | LOCK|!!T$<$ | LOCK|^m%S | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|b%&Bq?Np | LOCK|yD | $19B |